Diagnosis and Assessment of Euvolemic Hyponatremia in SIADH
Pathophysiologic Features
In patients with SIADH, total body sodium remains essentially normal, allowing differentiation from hypovolemic states (where sodium is lost) and hypervolemic states (where both sodium and water are retained)【1】【2】.
Euvolemia in SIADH is characterized by a central venous pressure (CVP) of 6–10 cm H₂O, indicating normal extracellular fluid volume despite a 5–10 % increase in total body water that is not clinically detectable【2】【3】【4】.
Clinical Volume Assessment
Physical examination in SIADH is typically unremarkable: no orthostatic hypotension, no peripheral edema, normal skin turgor, and normal jugular venous pressure【1】【2】.
Relying solely on physical examination to determine volume status has low sensitivity (≈ 41 %) and therefore should not be used in isolation【1】【3】.
Direct measurement of CVP (6–10 cm H₂O) provides a more reliable indicator of euvolemia in suspected SIADH【2】【4】【5】.
Saline‑loading tests help differentiate SIADH from true hypovolemia: patients with SIADH do not sustain a rise in plasma sodium after isotonic saline infusion, whereas hypovolemic patients typically do【1】【3】.
Laboratory Diagnostic Hallmarks
SIADH presents with hypotonic hyponatremia, defined by a serum osmolality < 280 mOsm/kg【6】.
A low serum uric acid level (< 4 mg/dL) has a positive predictive value of 73–100 % for SIADH, supporting the diagnosis when present【2】【3】【6】.
Required Exclusion of Mimicking Conditions
Before confirming SIADH, hypothyroidism and adrenal insufficiency must be excluded, as both can produce a similar hyponatremic profile【6】.
In neurosurgical patients, cerebral salt wasting (CSW) is the principal differential diagnosis; CSW is distinguished by true hypovolemia (CVP < 6 cm H₂O) rather than the euvolemia seen in SIADH【2】【4】【7】.
Limitations of ADH Measurement
- SIADH may occur even when plasma ADH levels are undetectable, indicating that direct ADH measurement has limited diagnostic utility【2】【6】.
Investigation of Choice for SIADH
Comprehensive Laboratory Assessment
- In patients whose serum sodium drops below 131 mmol/L, simultaneous measurement of serum osmolality, urine osmolality, urine sodium, and serum uric acid is recommended to evaluate for SIADH. 8
- A serum uric acid concentration < 4 mg/dL yields a positive predictive value of 73–100 % for diagnosing SIADH. 9
Volume‑Status Assessment
- Physical examination alone identifies euvolemia with only 41 % sensitivity and 80 % specificity, making it inadequate for volume‑status determination in suspected SIADH. 9
- Central venous pressure (CVP) measurement of 6–10 cm H₂O indicates euvolemia characteristic of SIADH and helps differentiate it from cerebral salt wasting, which shows CVP < 6 cm H₂O. 8, 9
- Reliance on physical examination alone misses hypovolemia in nearly 60 % of cases, underscoring the need for objective measures such as CVP. 9
Exclusion Criteria and Limited‑Value Tests
- Direct plasma ADH measurement is not recommended because it adds limited diagnostic value and SIADH can occur with undetectable ADH levels. 9
- Natriuretic peptide concentrations lack supporting evidence for routine diagnostic use in SIADH. 8
- The work‑up must exclude thyroid dysfunction, adrenal insufficiency, and hyponatremia‑inducing medications; a medication review is essential. 8
Diagnostic Algorithm Highlights
- In neurosurgical patients, cerebral salt wasting is the primary differential diagnosis; CVP measurement is required to distinguish it from SIADH. 8
- Urinary sodium < 30 mmol/L predicts saline responsiveness with a positive predictive value of 71–100 %, indicating hypovolemia rather than SIADH. 9